CHA News Article

DEA Reschedules Hydrocodone Combination Products

The Drug Enforcement Administration (DEA) has announced that it will move all hydrocodone combination products (HCPs) from federal Schedule III to the more restrictive Schedule II, adjusting how HCPs are prescribed and dispensed. The California State Board of Pharmacy will release official guidelines to assist pharmacies with the transition within approximately 30 days. To read the DEA’s rule 389 about the change, visit